This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Apr;23(2):175-83.

doi: 10.1080/08998280.2010.11928615.

New drugs approved in 2009

Erin Sears¹, Sarah Brooks

Affiliations

PMID: 21240318
PMCID: PMC2848098
DOI: 10.1080/08998280.2010.11928615

New drugs approved in 2009

Erin Sears et al. Proc (Bayl Univ Med Cent). 2010 Apr.

. 2010 Apr;23(2):175-83.

doi: 10.1080/08998280.2010.11928615.

Authors

Erin Sears¹, Sarah Brooks

Affiliation

¹ Department of Pharmacy Services, Baylor University Medical Center, Dallas, Texas.

PMID: 21240318
PMCID: PMC2848098
DOI: 10.1080/08998280.2010.11928615

No abstract available

PubMed Disclaimer

Similar articles

A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs.
Zeukeng MJ, Seoane-Vazquez E, Bonnabry P. Zeukeng MJ, et al. Eur J Clin Pharmacol. 2018 Jun;74(6):811-818. doi: 10.1007/s00228-018-2431-7. Epub 2018 Feb 22. Eur J Clin Pharmacol. 2018. PMID: 29470610
Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H, Song Y, Guan J, Luo L, Zhuang Z. Liu H, et al. BMC Bioinformatics. 2016 Dec 23;17(Suppl 17):539. doi: 10.1186/s12859-016-1336-7. BMC Bioinformatics. 2016. PMID: 28155639 Free PMC article.
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
Sacks LV, Shamsuddin HH, Yasinskaya YI, Bouri K, Lanthier ML, Sherman RE. Sacks LV, et al. JAMA. 2014 Jan 22-29;311(4):378-84. doi: 10.1001/jama.2013.282542. JAMA. 2014. PMID: 24449316
How cost-effective are new cancer drugs in the U.S.?
Lichtenberg FR. Lichtenberg FR. Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):39-55. doi: 10.1080/14737167.2020.1709965. Epub 2020 Jan 6. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31906739 Review.
[Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].
Dumortier G, Welniarz B, Sauvebois C, Medjdoub H, Friche H, Siad N, Degrassat K. Dumortier G, et al. Encephale. 2005 Jul-Aug;31(4 Pt 1):477-89. doi: 10.1016/s0013-7006(05)82409-1. Encephale. 2005. PMID: 16389715 Review. French.

See all similar articles

Cited by

Prognostic effect of a vasopressin V₂ receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet-cold pattern.
Matsushita K, Harada K, Miyamoto T, Iida K, Yamamoto Y, Shiraishi Y, Nagatomo Y, Yoshino H, Yamamoto T, Nagao K, Takayama M. Matsushita K, et al. Eur J Clin Pharmacol. 2024 Nov;80(11):1795-1805. doi: 10.1007/s00228-024-03745-y. Epub 2024 Aug 21. Eur J Clin Pharmacol. 2024. PMID: 39168874

References

1. ATryn¯ (antithrombin, recombinant) lyophilized powder for reconstitution [product information] Framingham, MA: GTC Biotherapeutics, Inc, April 2009.
1. Saphris¯ (asenapine) sublingual tablets [product information] Kenilworth, NJ: Schering Corp, August 2009.
1. Potkin SG, Cohen M, Panagides J. Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial. J Clin Psychiatry. 2007;68(10):1492–1500. - PubMed
1. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord. 2009;11(7):673–686. - PubMed
1. Besivance™ (besifloxacin) ophthalmic suspension, 0.6% [product information] Tampa, FL: Bausch & Lomb Inc, April 2009.

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central